For hospital procurement and compliance officers, the science of a gene panel matters less than the evidence that every result is reliable. The 98-gene gastric test is delivered under a documented quality system in which accreditation, standard operating procedures, and traceable batch controls are treated as part of the product, not an afterthought bolted on at the end.
Every sequencing run follows a validated standard operating procedure with positive and negative controls, and analytical performance is reviewed against accepted guidelines for somatic testing. Specimens are accessioned, extracted, and sequenced under chain-of-custody logging so a result can be traced back to the exact reagent lot and instrument. Variant calls pass through a secondary review before a certified report is released, and any call below the validated threshold is flagged rather than silently reported as definitive.
This quality framework is relevant whenever gastric testing is procured for clinical decision-making or for trials that require auditable results. It reassures regulators, payers, and partners that the 98-gene profile meets the same expectations as locally accredited molecular laboratories, and it protects patients from acting on an unverified call. Because the report is released only after secondary review, fewer ambiguous calls reach the clinic, which reduces the number of repeated biopsies requested purely to confirm a doubtful result.
The service accepts FFPE blocks or unstained slides with a completed requisition, and specimen suitability is confirmed before testing begins. Standard reporting is seven to ten business days, with the accreditation statement and control summary attached to each file for immediate review.
Shipping kits are validated for ambient or refrigerated transit, and each lot ships with a certificate of analysis. The supplier maintains documentation packages that procurement teams can submit during vendor qualification, including method validation summaries and limit-of-detection data. Temperature logging during transit is captured automatically, and any excursion outside the validated range is reported so the receiving lab can decide whether to accept or reject the batch before testing begins.
Q: What quality documents accompany the 98-gene report? A: Each report ships with the lab accreditation statement, run controls, and a lot certificate so the result is fully auditable.
Q: Are borderline variant calls reported anyway? A: Calls below the validated confidence threshold are explicitly flagged rather than released as definitive, protecting clinical decisions.
Q: Can procurement use this for vendor qualification? A: Yes, the documentation package is structured to support hospital and distributor qualification workflows.
For hospital procurement and compliance officers, the science of a gene panel matters less than the evidence that every result is reliable. The 98-gene gastric test is delivered under a documented quality system in which accreditation, standard operating procedures, and traceable batch controls are treated as part of the product, not an afterthought bolted on at the end.
Every sequencing run follows a validated standard operating procedure with positive and negative controls, and analytical performance is reviewed against accepted guidelines for somatic testing. Specimens are accessioned, extracted, and sequenced under chain-of-custody logging so a result can be traced back to the exact reagent lot and instrument. Variant calls pass through a secondary review before a certified report is released, and any call below the validated threshold is flagged rather than silently reported as definitive.
This quality framework is relevant whenever gastric testing is procured for clinical decision-making or for trials that require auditable results. It reassures regulators, payers, and partners that the 98-gene profile meets the same expectations as locally accredited molecular laboratories, and it protects patients from acting on an unverified call. Because the report is released only after secondary review, fewer ambiguous calls reach the clinic, which reduces the number of repeated biopsies requested purely to confirm a doubtful result.
The service accepts FFPE blocks or unstained slides with a completed requisition, and specimen suitability is confirmed before testing begins. Standard reporting is seven to ten business days, with the accreditation statement and control summary attached to each file for immediate review.
Shipping kits are validated for ambient or refrigerated transit, and each lot ships with a certificate of analysis. The supplier maintains documentation packages that procurement teams can submit during vendor qualification, including method validation summaries and limit-of-detection data. Temperature logging during transit is captured automatically, and any excursion outside the validated range is reported so the receiving lab can decide whether to accept or reject the batch before testing begins.
Q: What quality documents accompany the 98-gene report? A: Each report ships with the lab accreditation statement, run controls, and a lot certificate so the result is fully auditable.
Q: Are borderline variant calls reported anyway? A: Calls below the validated confidence threshold are explicitly flagged rather than released as definitive, protecting clinical decisions.
Q: Can procurement use this for vendor qualification? A: Yes, the documentation package is structured to support hospital and distributor qualification workflows.
english
français
Deutsch
Italiano
Русский
Español
português
Nederlandse
ελληνικά
日本語
한국
العربية
हिन्दी
Türkçe
indonesia
tiếng Việt
ไทย
বাংলা
فارسی
polski
